No Data
INKON Life Technology (300143.SZ): Currently, there is no collaboration with Huawei Medical large model.
On February 19, Gelonghui reported that INKON Life Technology (300143.SZ) stated on the investor interaction platform that the company has not yet collaborated with Huawei Medical's large model. INKON Life Technology has been focusing on "AI + Medical" since 2021 and has currently introduced an intelligent interaction platform built with the capabilities of Iflytek Co.,ltd. The platform has officially launched at Shanxi INKON Life Technology General Hospital, marking a milestone in the company's innovative applications in the AI medical field, transitioning into a new phase of full-scenario applications. In the future, INKON Life Technology will continue to drive AI + clinical medical applications, explore AI innovation applications, promote AI product research and development, and create a comprehensive health system for users.
INKON Life Technology (300143.SZ): Currently, it has not yet integrated with the DeepSeek large model.
On February 19, Gelonghui reported that INKON Life Technology (300143.SZ) stated on the investor interaction platform that the company has not yet integrated with the DeepSeek large model. However, the group's health ecosystem brand, INKON One Life's AI platform, INKON Brain, and digital intelligence products have recently integrated with the DeepSeek-R1 large model. INKON Life Technology will arrange relevant work according to the group's unified deployment and will continue to drive innovation in AI applications in clinical medicine, advance AI product research and development, and create a new model for comprehensive user health management throughout the entire cycle.
INKON Life Technology (300143.SZ): Recently introduced an intelligent interactive platform built using the model capabilities of Iflytek Co.,ltd.
Glory Holdings reported on February 19 that INKON Life Technology (300143.SZ) stated on the investor interactive platform that the company recently introduced an intelligent interactive platform built with the large model capabilities of Iflytek Co.,ltd. It has officially launched at the Shanxi INKON Life General Hospital, marking a milestone in the company's innovative application in the AI Medical field as it steps into a new stage of full-scenario application. Since 2021, INKON Life Technology has laid out the "AI + Medical" strategy, focusing on three main directions: "precise diagnosis and treatment," "enhancing patient experience," and "refined operation," along with "3D visualization scenarios," "imaging diagnostic scenarios," "case generation scenarios," "radiation therapy scenarios," "intelligent follow-up scenarios," and "smart...
Should You Investigate INKON Life Technology Co., Ltd. (SZSE:300143) At CN¥9.39?
INKON Life Technology (300143.SZ): The company is currently promoting the standardization of critical care rehabilitation specialist capabilities and standard nursing capabilities in its internal hospitals.
On December 17, Gelonghui reported that INKON Life Technology (300143.SZ) stated on the investor interaction platform that the company is seizing the opportunities presented by the Silver Economy's development, actively advancing the CSI Old-Age Industry Index, and through the construction of regional medical centers and digital platforms, achieving a comprehensive medical service industry closed loop and capacity building that integrates serious medical care, intensive rehabilitation, and nursing care. Currently, the health and nursing Business relies on Shanghai INKON Nursing Group, which has already managed Shanghai INKON and Xujing Nursing Home among others. The Xujing Town Care Home serves as the first pilot for the 'home care bed service' in Xujing Town, Qingpu District, Shanghai, extending professional care services into the homes of elderly individuals.
zheshang Securities: Nuclear technology applications have wide downstream applications and enormous growth potential.
In 2022, the output value of non-power nuclear technology applications in our country accounted for approximately 0.57% of GDP, showing significant growth potential compared to developed countries overseas (which account for 2-3% of GDP).
